Evidence map›Paper›PMID 39995378›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2025

Amyloid-Templated Ceria Nanozyme Reinforced Microneedle for Diabetic Wound Treatments.

Qize Xuan, Jiazhe Cai, Yuan Gao, Xinchi Qiao, Tonghui Jin, Mohammad Peydayesh, Jiangtao Zhou, Qiyao Sun, Lijian Zhan, Bin Liu and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Bioelectronic Considerations in Biomedical Microneedles.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  8. Integrated OAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Biomimetic materials for medical applications.Chinese medical journal · 2026
    Review
  15. Article
  16. Review
  17. Catalytic Amyloids: Turning Fibrils Into Biocatalysts.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Qize XuanInstitute for Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, P. R. China.
Jiazhe CaiInstitute for Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, P. R. China.
Yuan GaoInstitute for Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, P. R. China.
Xinchi QiaoInstitute for Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, P. R. China.
Tonghui JinDepartment of Health Sciences and Technology, ETH Zürich, Schmelzbergstrasse 9, Zürich, 8092, Switzerland.
Mohammad PeydayeshDepartment of Health Sciences and Technology, ETH Zürich, Schmelzbergstrasse 9, Zürich, 8092, Switzerland.
Jiangtao ZhouDepartment of Health Sciences and Technology, ETH Zürich, Schmelzbergstrasse 9, Zürich, 8092, Switzerland.
Qiyao SunDepartment of Health Sciences and Technology, ETH Zürich, Schmelzbergstrasse 9, Zürich, 8092, Switzerland.
Lijian ZhanInstitute for Biomedical Engineering, ETH Zürich, Zürich, 8092, Switzerland.
Bin LiuDepartment of Health Sciences and Technology, ETH Zürich, Schmelzbergstrasse 9, Zürich, 8092, Switzerland.ORCID https://orcid.org/0000-0003-3969-3484
Ping WangDepartment of Bioproducts and Biosystems Engineering, University of Minnesota, St Paul, MN, 55108, USA.
Hui LiInstitute for Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, P. R. China.
Chao ChenInstitute for Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, P. R. China.ORCID https://orcid.org/0009-0000-2809-9979
Raffaele MezzengaDepartment of Health Sciences and Technology, ETH Zürich, Schmelzbergstrasse 9, Zürich, 8092, Switzerland.ORCID https://orcid.org/0000-0002-5739-2610

Funding

China Postdoctoral Science Foundation 2024M761917China Scholarship Council 202206740021National Natural Science Foundation of China 42125706National Natural Science Foundation of China 42407582National Natural Science Foundation of China 42477424Natural Science Foundation of Shanghai 22ZR1415400Shanghai Pujiang Program 24PJD038Shanghai Rising-Star Program 23QC1400500Shanghai Rising-Star Program 24YF2712200
6 · The paper itself

Abstract

Amyloid fibrils have emerged as excellent templates and building blocks for the development of ordered functional materials with considerable potential in biomedical applications. Here, lysozyme amyloid fibrils (Lys-AFs) are employed as templates for the in situ synthesis of ceria nanozymes (Lys-AFs-Ceria) with ultrafine dimensions, an optimized Ce

Indexed as

AmyloidCeriumWound HealingAnimalsAnti-Bacterial AgentsCatalaseDiabetes Mellitus, ExperimentalGlucose OxidaseHydrogelsMaleMiceMuramidaseAmyloidAnti-Bacterial AgentsCatalaseCeriumGlucose OxidaseHydrogelsMuramidaseamyloid fibrilsceria nanozymesdiabetic woundmicroenvironment regulationmicroneedle

Identifiers

PMID39995378
PMCPMC12004906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.